Rattanatanyapat P.Suan-ek P.Saokaew S.Phisalprapa P.Mongkhon P.Mahidol University2026-02-062026-02-062026-01-01European Geriatric Medicine (2026)18787649https://repository.li.mahidol.ac.th/handle/123456789/114565Aim: This study aimed to investigate the effects of antidementia drugs (ADDs), including cholinesterase inhibitors (CEIs) and memantine, on nursing home placement (NHP) among individuals with dementia. Findings: ADDs may be associated with a lower risk of NHP, with a 57% reduction in Alzheimer’s disease and a 16% reduction in mixed-type dementia. There were no significant difference in NHP risk between donepezil and rivastigmine, or between donepezil and galantamine, or combining CEIs with memantine and CEIs monotherapy. Message: ADDs are associated with a reduced risk of NHP; however, future trials or well-designed studies are needed to understand the reasons for this association and to determine whether it is causal.NursingMedicineArticleSCOPUS10.1007/s41999-025-01398-32-s2.0-1050275532101878765741528688